ACT UP London
United Kingdom
London activists push Gilead to lower price of new HIV drug

Protesters condemn Gilead for prioritizing exorbitant profits over public health, accusing the pharmaceutical company of obstructing widespread generic production of new HIV drug lenacapavir


    All text content published on peoplesdispatch.org is the property of Peoples Dispatch and is under a Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA) license.
    For license to republish any audio, video or image content, please get in touch with the Peoples Dispatch Team.
    Share on Facebook Share
    Share on Twitter Tweet
    Share on Reddit Share
    Share on Whatsapp Share
    Send email Mail
    Print this Print